Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
NEW YORK, N.Y. — [March 14, 2024]: Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on a Phase 1 trial of the company novel NK cell-based therapy AlloNK® (also known as AB-101), in combination with anti-CD20 antibodies, for patients with active lupus nephritis – inflammation […] READ MORE
Celebrating Patti Allen – A Woman Dedicated to Advocating for All with Lupus
March 4, 2024 Forget the old saying that March comes in like a lion and goes out like a lamb. At the Lupus Research Alliance, March is a time for intense, month-long action: when we salute Women’s History Month as well as advocate together on the Hill for lupus research funding. Spotlighting a strong and […] READ MORE
Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
New York, NY, February 28. The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE). The LMTA provides investigators up to $600,000 […] READ MORE
Embracing the Arts to Educate and Advocate
February 1, 2024 In honor of Black History Month, we bring you the story of eloquent poet performer and lupus advocate Shanelle Gabriel. With a focus on the theme “African Americans and the Arts,” Black History Month is a perfect time to hear from Shanelle, a woman who uses her poetry and music to elevate […] READ MORE
Re-engineering Immune Cells Opens Door to Promising Therapy for Lupus Kidney Inflammation
Research Published in Nature Communications and Funded in Part by the Lupus Research Alliance Could Correct a Defect in Lupus NEW YORK, NY. February 6. Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious and potentially […] READ MORE
Lupus Research Alliance 2023 Dr. William E. Paul Distinguished Innovator Award Granted to Yale School of Medicine Researcher Akiko Iwasaki, Ph.D.
Research Will Explore How Ancient Viral Remnants in Our DNA Trigger Lupus NEW YORK, NY – January 30. The Lupus Research Alliance (LRA) is pleased to grant the 2023 Dr. William E. Paul Distinguished Innovator Award (DIA) to Akiko Iwasaki, Ph.D., Sterling Professor of Immunobiology at the Yale School of Medicine. Dr. Iwasaki will investigate […] READ MORE
Championing Patient Power in Lupus
January 24, 2024 Dr. Stacie Bell came to LRA’s clinical research affiliate Lupus Therapeutics (LT) one year ago to help fulfill the vision of an entire community united to triumph over a complex and confounding disease. She joined determined to work with the researchers, clinicians, biopharmaceutical companies, and most importantly the people with lupus and […] READ MORE
Running for Lupus Research – Meet Brittany Morris
January 18, 2024 Brittany Morris was supposed to be a professional athlete. As a child, she was one of her community’s fastest track stars, a sprinter with big plans to compete as a pro-runner, at least with a scholarship to join a college team. But suddenly at 12 years old she developed confusing symptoms that […] READ MORE
Lupus Research Alliance Mourns the Loss of Congresswoman Eddie Bernice Johnson
January 2, 2024 The national lupus community lost a passionate advocate with the passing of former Congresswoman Eddie Bernice Johnson (D-TX). As many have shared, Congresswoman Johnson was a woman of significant “firsts” – first Black head psychiatric nurse at the Dallas VA hospital, first nurse elected to Congress, first African American and first woman […] READ MORE
Angelica Perez Finds a Simple Way to Make a Huge Difference – You Can Too!
December, 2023 Participating in the LRA’s Lupus Landmark Study was a “no-brainer” says Angelica Perez, a 37-year-old woman living with lupus since she was nine. “I had been taking part in clinical trials for years to potentially improve my own care while helping to advance new treatments overall.” A patient of renowned Los Angeles lupus […] READ MORE
Study Reported Telitacicept Showed Favorable Effectiveness and Safety for SLE
Dec. 1, 2023 A new paper published in Lupus Science & Medicine on the results of a study in China reported that a potential treatment telitacicept demonstrated favorable effectiveness and safety in patients with active SLE. It also improved effects of lupus on kidneys and the blood. Telitacicept is conditionally approved in China as a […] READ MORE
Summary Highlights of Important Research Presented at ACR Convergence 2023
November, 2023 At the recent ACR Convergence 2023, the annual meeting of the American College of Rheumatology, important lupus clinical trial data and breakthrough foundational research were presented. Following are highlights of work funded by the Lupus Research Alliance or supported in partnership with industry through our clinical affiliate Lupus Therapeutics. CAR-T Cell Therapy is […] READ MORE
